Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127 | NeoGenomics Laboratories

Publication date

Fri, 02/02/2024 - 12:00

Category

Year

Subtitle

Science

External link

https://pubmed.ncbi.nlm.nih.gov/38301010/

Division